|
| 34108669 | CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy. | Cancer Gene Therapy | 2022 |
| 33262221 | Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity. | Molecular Cancer Therapeutics | 2021 |
| 33897445 | cAMP-Dependent Signaling Restores AP Firing in Dormant SA Node Cells via Enhancement of Surface Membrane Currents and Calcium Coupling. | Front Physiol | 2021 |
| 33465468 | Tumor Epigenetic Signature and Survival in Resected Gastric Cancer Patients. | Journal of the American College of Surgeons | 2021 |
| 32032721 | Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer. | Journal of the American College of Surgeons | 2020 |
| 32158622 | Oncolytic poxvirus CF33-hNIS-οF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model. | OncoImmunology | 2020 |
| 26729520 | AGE-RAGE signal generates a specific NF-κB RelA "barcode" that directs collagen I expression. | Scientific Reports | 2016 |
| 26057358 | Central relaxin-3 receptor (RXFP3) activation reduces elevated, but not basal, anxiety-like behaviour in C57BL/6J mice. | Behavioural Brain Research | 2015 |
| 24949629 | Mechanism for adhesion G protein-coupled receptor GPR56-mediated RhoA activation induced by collagen III stimulation. | PLoS ONE | 2014 |
| 24132639 | Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index. | Science Translational Medicine | 2013 |
| 21894173 | ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway. | Immunology and Cell Biology | 2012 |
| 22789540 | Proapoptotic activation of death receptor 5 on tumor endothelial cells disrupts the vasculature and reduces tumor growth. | Cancer Cell | 2012 |
| 22675435 | Priority medicines for maternal and child health: a global survey of national essential medicines lists. | PLoS ONE | 2012 |
| 21251615 | An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells. | Cancer Cell | 2011 |
| 20644729 | Genome-wide mapping indicates that p73 and p63 co-occupy target sites and have similar dna-binding profiles in vivo. | PLoS One | 2010 |
| 20813513 | Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation. | Current Opinion in Cell Biology | 2010 |
| 19763140 | Conformational stability and activity of p73 require a second helix in the tetramerization domain. | Cell Death Differ | 2009 |
| 18258921 | Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targets. | Genome Res | 2008 |
| 17571346 | Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. | Nature | 2007 |
| 17397906 | A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expression. | Human Pathology | 2007 |
| 17122775 | p63 protects the female germ line during meiotic arrest. | Nature | 2006 |
| 17188034 | Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. | Mol Cell | 2006 |
| 18265358 | Chromatin immunoprecipitation for determining the association of proteins with specific genomic sequences in vivo. | Current Protocols in Molecular Biology | 2005 |
| 15994791 | Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. | J Virol | 2005 |
| 15837625 | Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. | Cancer Cell | 2005 |
| 15249685 | Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. | Proc Natl Acad Sci U S A | 2004 |
| 11932750 | p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. | Nature | 2002 |
| 12453409 | REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. | Molecular Cell | 2002 |
| 12446779 | A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. | Mol Cell Biol | 2002 |
| 11818141 | On the shoulders of giants: p63, p73 and the rise of p53. | Trends in Genetics | 2002 |
| 12368184 | p63 Coordinates anogenital modeling and epithelial cell differentiation in the developing female urogenital tract. | American Journal of Pathology | 2002 |
| 11159940 | Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. | Hum Mol Genet | 2001 |
| 11727253 | Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. | Human Pathology | 2001 |
| 11381365 | Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases. | Human Pathology | 2001 |
| 11683994 | Drosophila LAR regulates R1-R6 and R7 target specificity in the visual system. | Neuron | 2001 |
| 11136566 | Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63. | Gynecologic Oncology | 2001 |
| 11136565 | Expression of the p53 homologue p63 in early cervical neoplasia. | Gynecologic Oncology | 2001 |
| 11106548 | p63 is a prostate basal cell marker and is required for prostate development. | Am J Pathol | 2000 |
| 10894779 | An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. | Science | 2000 |
| 11023104 | Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia? | American Journal of Surgical Pathology | 2000 |
| 10945600 | Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. | Cancer Research | 2000 |
| 11252895 | P63 and P73: P53 mimics, menaces and more. | Nature Reviews Molecular Cell Biology | 2000 |
| 10872669 | Adenoid basal carcinomas of the cervix: a unique morphological evolution with cell cycle correlates. | Human Pathology | 2000 |
| 10716451 | p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. | Nature | 2000 |
| 10535733 | Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. | Cell | 1999 |
| 10594758 | Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. | Journal of Investigative Dermatology | 1999 |
| 10227294 | p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. | Nature | 1999 |
| 9774969 | p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. | Mol Cell | 1998 |
| 9288759 | Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. | Cell | 1997 |